23 March 2016 - The Scottish Medicines Consortium has approved funding for the use across NHS Scotland of a uterine fibroid treatment that could enable some women to avoid hysterectomies.

Gedeon Richter’s Esmya (ulipristal acetate) is a once-daily pill that controls bleeding, reduces anaemia and shrinks the size of fibroids compared with baseline, used to treat women with moderate to severe uterine fibroids.

For more details, go to: http://www.pharmatimes.com/Article/16-03-23/SMC_allows_wider_use_of_Gedeon_Richter_s_Esmya.aspx